Marker Therapeutics, Inc. Common Stock MRKR
$1.11
-5.93%
at last close
Financials (TTM)
- Revenue
- $3.95 million
- Net Income
- $-10,896,714
- Net Margin
- -275.92%
- Return on Equity
- -78.98%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.43
- Price / Sales
- 4.98
Over the trailing twelve months, Marker Therapeutics, Inc. Common Stock generated revenue of $3.95 million and net income of $-10,896,714, a net margin of -275.92%.
At the last closing price of $1.11, MRKR trades at 4.98 times sales, with a market capitalization of $19.67 million.
Key Stats
- Last Close
- $1.11
- Market Cap
- $19.67 million
- 52-Week Range
- $0.81 – $4.07
- Average Volume
- 58K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.